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Are there any association between polycistic ovary syndrome and
congenital abnormalities of Müllerian ducts
Da li postoji udruženost sindroma policistiþnih ovarijuma i uroÿenih anomalija
Milerovih kanala
Aleksandra Tubiü-Pavloviü, Dragana Radoviü-Janoševiü, Aleksandra Petriü,
Milan Stefanoviü
Clinic of Gynecology and Obstetrics, Clinical Center Niš, Niš, Serbia
Abstract
Background/Aim. There are many specificities of merital
infertility and sometimes surprising connections between
some thinks with no connections at first sight. Examina-
tions of these patients imply diagnostic actions such as the
blood basal hormone sample, doing hysterosalpingogra-
phy, ultrahysterosonography, ultrasound examinations,
and sometimes laparoscopy and hysteroscopy if there are
necessary. The aim of the study was to determine the
characteristics of the connection between policystic ovary
(PCO) syndrome (Sy) and congenital Müllerian ducts ab-
normalities.  Methods. This study included 356 patients
treated in the period from January 1, to December 31,
2009, in the Department of Infertility of the Clinic for
Obstetrics and Gynecology in Niš, Serbia. Exclusion crite-
ria were no myoma, ovary cysts, tubal and male factors of
infertility. Results. A total of 180 patients were divided
into 3 groups: the group I with PCO sy, the group II with
uterine congenital malformation and the group III with a
combination of these disorders. The middle age of pa-
tients was 29.6 ± 4.8, body mass index (BMI) was 26.1 ±
4,8 kg/m2 the middle thicknes of endometrium was 5.2 +
2.7 mm, and there were no significant differences between
the examined groups. There were no significant among in
a number of miscarriages in the examined groups. We
found that PCO Sy and congenital abnormalities of Mülle-
rian ducts were conjoint in 30% of examined patients.
Conclusion.  Conjoined PCO Sy and congenital abnor-
malities of Müllerian ducts do not result in a higher num-
ber of misscarriages than only either PCO Sy or abnor-
malities of Müllerian ducts. It is important to check BMI,
basal level of follicle stimulating hormone and number of
antral follicles because the induction protocol and con-
centracion of inductors depends on these characteristics,
thus, the succsessful cycles and pregnancy.
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Apstrakt
Uvod/Cilj. Postoje mnoge specifiÿnosti u ispitivanju braÿ-
nog steriliteta koje ponekad mogu da nas iznenade svojom
pojavom, povezanošýu ili moguýom zajedniÿkom genskom
ekspresijom. Tako, moguýa je i povezanost sindroma polici-
stiÿnih ovarijuma (PCOS) i kongenitalnih malformacija Mi-
lerovih kanala. Cilj rada bio je da se utvrde karakteristike
povezanosti PCOS i kongenitalnih malformacija Milerovih
kanala. Metode. Studijom je bilo obuhvaýeno 356 infertil-
nih žena leÿenih u periodu od 1. januara 2008. do 31. de-
cembra 2009. u Ginekološko-akušerskoj klinici u Nišu. Pa-
cijentkinje sa miomima, cistama jajnika, tubarnim sterilite-
tom, kao i infertilni muškarci nisu ukljuÿeni u studiju. Re-
zultati. Ukupno 180 pacijentkinja bilo je podeljeno u tri
grupe: grupa sa kongenitalnim malformacijama Milerovog
kanala, grupa sa PCOS i grupa sa udružene obe pojave. Pro-
seÿna starost pacijentkinja iznosila je 29,6 ± 3,7 g, srednja
vrednost indeksa telesne mase (BMI) 26,1 ± 4,8 kg/m2, a
srednja vrednost debljine endometrijuma 5,2 ± 2,7 mm.
Nije utvrĀena statistiÿki znaÿajna razlika meĀu grupama za
navedene parametre izuzev za BMI. Nije bilo znaÿajne razli-
ke u broju pobaÿaja meĀu ispitivanim grupama. Kombina-
cija PCOS i kongenitalnih malformacija Milerovih kanala
utvrĀena je kod 30% ispitivanih pacijentkinja. Zakljuÿak.
Udruženost ispitivanih pojava nema uticaja na poveýanje in-
cidencije spontanih pobaÿaja, ali treba obratiti pažnju na
prateýe faktore kao što je BMI, bazalni uzorak folikulosti-
mulirajuýeg hormona i broj antralnih folikula jer oni, tako-
Āe, govore o kvalitetu jajnih ýelija koje sazrevaju.
Kljuÿne reÿi:
jajnik, policistiÿni, sindrom; materica; anomalije;
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Introduction
In everyday work sometimes some specific and un-
common thinks at first sight can be found. Examinations
such as blood basal hormone samples, hysterosalpingogra-
phy, ultrahysterosonography, ultrasound examinations and
sometimes laparoscopy and hysteroscopy are perfomed
sometimes. But there are some investigations with the aim to
find the connections between polycystic ovary syndrome
(PCO sy) 
1 and congenital abnormalities of Müllerian ducts 
2
as well as different genes expressions. In that case there is no
difference between mild or other forms of congenital Mülle-
rian abnormalities. Genes which are maybe involved are
WNT genes probably WNT 4. WNT4 gene has influence on
growth factor for development of kidney, adrenal glands,
mammary glands, pituitary glands and female reproductive
tracts. With late development of that gene locus, masculasa-
tions happens in female fetus as well as stronger steroido-
genesis 
3. WNT5, WNT7, HOXA 10 and HOXA 11 genes
locus have a very important part in regulation uterus stroma
as well as production estrogens and progesterons. WNT and
HOXA genes are both important in developing anteroposte-
rior axis of reproductive tract. It means that in special condi-
tions their expression influences the different development of
Müllerian ducts and ovaries.
The aim of the study was to determine if the connec-
tions between PCO sy and congenital Müllerian ducts ab-
normalities exist.
Methods
This study included 356 patients treated in the period
from January 1, 2008 to December 31, 2009, in the Depart-
ment of Infertility in Clinic for Obstetrics and Gynecology in
Niš. All the patients with myoma, ovary cists, tubular and
male factors of infertility were excluded. A total of 180 pa-
tient left, so they were divided into 3 groups: the group I
with PCO sy, the group II with uterine congenital malforma-
tions and the group III with a combination of these disorders.
The patients were examined using the protocols: basal
blood hormone sample, hysterosalpingography or ultrahis-
terosonography. If the diagnosis of PCO sy was made oral
insulin glucose test with the level of insulin, ultrasound ex-
amination, and endoscopic procedures, if necessary, were
also performed.
Also, we investigated variables like body mass index
(BMI), age, as well as the number of miscarriages.
All the results were statistically analyzed and shown as
mean values standard deviation. The difference was statisti-
cally significant when p < 0.05.
Results and discussion
The percentage of association between PCO sy and
Müllerian duct congenital abnormalities was about 30 but as
we cannot find the similar datas in the literature, it is hard to
compare. The clinical and epidemiological features of the
group of patients with PCO sy and the group with the combi-
nation of PCO sy and congenital Millerian abnormalities are
shown in Table 1. There is no significant difference between
the examined groups in any variables except BMI (Table 2).
Also, there were no significant differences in a number of
misscarrigies among the groups (Table 3). If we compare con-
genital Müllerian abnormalities in our study (Table 4) and the
literature data the percentage of them is similar, except uterus
bicornis and arcuatus which differs a little; there were more
bicornis than other abnormalities. Usually, the biggest preva-
lence had uterus arcuatus (Table 5). It could be the result of
Table 1
Clinical and epidemiological characteristics of the patients
Characteristics
PCO sy  and con-
genital Müllerian
abnormalities
PCO sy Total
Patients (n) 60 60 120
Age (years) x ± SD 29.7 ± 3.5 30.1 ± 3.6 29.6 ± 3.7
BMI (kg/m
2), x ± SD 25 ± 0.46 27.1 ± 4.5 26.1 ± 4.6
Duration  of infertility
 (years), x ± SD 3.4 ± 2.4 3.6 ± 2.3 3.5 ± 2.4
Endomerial thickness
 2–4 days (mm), x ± SD 4.8 ± 2.2 5.8 ± 3.2 5.2 ± 2.7
FSH  2–4.days (miV/mL),
x ± SD 6.1 ± 2.0 5.9 ± 1.9 5.2 ± 2.7
The antral follicle count (n),
 x ± SD 18.3 ± 14.2 21.5 ± 16.2 20.2 ± 15.7
PCO sy – policystic ovary syndrome; BMI – body mass index; FSH – follicle stimulating hormone.
Table 2
Body mass index (BMI) in the studied groups of patients
BMI (kg/m
2) Groups of patients < 20 20–29 ! 20
PCO Sy, n 6* 49 5
Mixed, n 0 55 5
PCO sy – policystic ovary syndrome; Mixed – PCO sy and congenital
Müllerian abnormalities; *PCO sy vs mixed p < 0.05 (statistically significant).Strana 578 VOJNOSANITETSKI PREGLED Volumen 71, Broj 6
Tubiý-Pavloviý A, et al. Vojnosanit Pregl 2014; 71(6): 576–579.
different diagnosis procedures such as hysterosalpingography,
hysteroscopy, ultrasound, and it is also possible that the inves-
tigator can have his/her personal opinion.
There are no significance differences between miscar-
riages in the group with PCO sy and the group PCOsy and
Müllerian congenital abnormalities, so it means that perinatal
outcome is not worse if we have there two problems con-
joined. It means that if we make good diagnostic procedures
we can treat PCO sy as well as congenital Müllerian abnor-
malities and have good results. Literature data have reported
successful results between 10% and 65%, our were about
11%.
Some studies prove a significant difference between
those with uterine malformations and those with normal
uterus in the abortion rate, and preterm deliveries. It is ex-
pected, but we did not have a group with the normal uterus
because it was not the aim of our study. The patients with
didelphys and unicornuate uterus have similar effect on re-
production, because we can considered that didelphys is
symmetrical duplication of unicornuate uterus. Patients
with bicornuate uterus also have a poor pregnancy out-
come, so patients with partial bicornis have a better preg-
nancy outcome than patients with a complete one. Even if
there are no differences between the number of miscar-
riages, the highest number is in the group with PCO sy with
one miscarriage, two had only one, and more than two
none. It means that patients after one miscarriage go to
concluding and other diagnostic procedures (ultrasound or
hysteroscopy) as well as resection of septum, metroplasty
or medicaments for PCO sy.
It seems that the patients with uterine malformations
have high abortion and delivery rates as well as low deliv-
ery rates from their first pregnancy to the every next preg-
nancy.
It is very interesting, if there are any differences be-
tween BMI in different groups, what are the values of basal
blood hormone samples, and the measurements of endome-
trium on the day 4 following ultrasound. Our results demon-
strated that the middle age of patients was 29.6 ± 3.7, BMI
26.1 ± 4.8 kg/m
2 and the middle thicknes of endometrium 5.2
± 2.7 mm with no significant differences among the groups.
The number of miscarriages was equal in the groups
and similar to the literature data (from 10% to 60%), and if
similar multicentric investigatations are performed, we can
have good results, for instance higher number of ovulations
can improve perinatal outcome. It means that the improved
quality of ovarian cells will result in good ovulation and
pregnancy 
4. Some studies have examined the pregnancy
outcome in patients with untreated uterine malfomations
and their pregnancy rate is exactly the same in their first
and later pregnancies as the abortion, and the preterm deliv-
ery rates 
5–7.
It has been very imoprant to identify all endocrinologi-
cal, clinical and ultrasound disorders which can influnce
ovulations.
We do not speak about the level of basal follicle stimu-
lating hormone (FSH), which is also very important for the
protocol of induction of ovulations, as well as the types of
drugs and their effects.
BMI, and age are also important. Women with higher
BMI could have more antral follicles, but lower intermediate
and higher, as we can see in many multicentric studies. It
should be kept in mind and, if necessery, to use different
protocol of ovulation.
Table 3
The number of miscarriages in the studied groups of patients
Miscarriages Groups of patients One Two  Three
Mixed, n (%) 3 (5) 2 (3.3) 2 (3.3)
PCO Sy, n (%) 6 (10) 1 (1.7) 0 (0)
PCO sy – policystic ovary syndrome; Mixed – Müllerian ducts abnormalities conjoined with policystic ovary syndrome.
Table 4
Congenital anomalies of Müllerian ducts in the different groups
Anomalies Group of patient Arcuatus Bicornis Unicornus Duplex Subseptus Septus
Mixed, n (%) 24 (40) 20 (30.3) 2 (3.3) 2 (3.3) 10 (16.5) 2 (3.3)
Müllerian ducts
abnormalities, n (%)
24(40) 24 (40) 4 (6.6) 4 (6.6) 4 (6.6) 4 (6.6)
Mixed – Müllerian ducts abnormalities conjoined with policystic ovary syndrome.
Table 5
The number of miscarriages depending on the type of anomaly
Miscarriages (n) Anomalies Mixed group Müllerian abnormalities group
Arcuatus 2 2
Bicornus 2 1
Unicornus 0 0
Duplex 0 2
Subseptus 1 1
Septus 0 1
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Conclusion
Conjoined PCO sy and congenital abnormalities of
Müllerian ducts do not result in the higher number of miscar-
riages. It is important to check BMI, basal level of FSH and
number of antral follicles because the induction protocol and
concentration of inductors depend on these characteristics,
and consequently the successesful cycles and pregnancy.
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